Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 260 entries
Sorted by: Best Match Show Resources per page
Creating Career Opportunities for Women with Autism in STEM

Stem career interventions

Griffiths AJ.
GSID: X7QEqO9V5N0J
AJ Griffiths, AM Nash, ZD Maupin, R Delgado… - Generation A, 2022 - emerald.com

Over the next 25 years, STEM (science, technology, engineering, and mathematics) occupations will increase at rates higher than those in any other professional field. The inevitable rise in career opportunities, and the multiplicative impact across technology in a wide...

Cite
Griffiths, A. J., Nash, A. M., Maupin, Z. D., Delgado, R., & Mathur, S. K. (2022). Creating Career Opportunities for Women with Autism in STEM. In Generation A (pp. 3-21). Emerald Publishing Limited.
Griffiths, Amy Jane, et al. "Creating Career Opportunities for Women with Autism in STEM." Generation A. Emerald Publishing Limited, 2022. 3-21.
Copy Download .nbib Format: MLA
THE EFFICACY OF AN EIGHT-WEEK CORE STABILIZATION PROGRAM ON CORE MUSCLE FUNCTION AND ENDURANCE: A RANDOMIZED TRIAL.

International journal of sports physical therapy

Hoppes CW, Sperier AD, Hopkins CF, Griffiths BD, Principe MF, Schnall BL, Bell JC, Koppenhaver SL.
PMID: 27525175
Int J Sports Phys Ther. 2016 Aug;11(4):507-19.

BACKGROUND: Body armor is credited with increased survival rates in soldiers but the additional axial load may negatively impact the biomechanics of the spine resulting in low back pain. Multiple studies have found that lumbar stabilization programs are superior...

Cite
Hoppes CW, Sperier AD, Hopkins CF, et al. THE EFFICACY OF AN EIGHT-WEEK CORE STABILIZATION PROGRAM ON CORE MUSCLE FUNCTION AND ENDURANCE: A RANDOMIZED TRIAL. Int J Sports Phys Ther. 2016;11(4):507-19
Hoppes, C. W., Sperier, A. D., Hopkins, C. F., Griffiths, B. D., Principe, M. F., Schnall, B. L., Bell, J. C., & Koppenhaver, S. L. (2016). THE EFFICACY OF AN EIGHT-WEEK CORE STABILIZATION PROGRAM ON CORE MUSCLE FUNCTION AND ENDURANCE: A RANDOMIZED TRIAL. International journal of sports physical therapy, 11(4), 507-19.
Hoppes, Carrie W, et al. "THE EFFICACY OF AN EIGHT-WEEK CORE STABILIZATION PROGRAM ON CORE MUSCLE FUNCTION AND ENDURANCE: A RANDOMIZED TRIAL." International journal of sports physical therapy vol. 11,4 (2016): 507-19.
Hoppes CW, Sperier AD, Hopkins CF, Griffiths BD, Principe MF, Schnall BL, Bell JC, Koppenhaver SL. THE EFFICACY OF AN EIGHT-WEEK CORE STABILIZATION PROGRAM ON CORE MUSCLE FUNCTION AND ENDURANCE: A RANDOMIZED TRIAL. Int J Sports Phys Ther. 2016 Aug;11(4):507-19. PMID: 27525175; PMCID: PMC4970841.
Copy Download .nbib Format: NLM
Compound Stimulus Presentation Does Not Deepen Extinction in Human Causal Learning.

Frontiers in psychology

Griffiths O, Holmes N, Westbrook RF.
PMID: 28232809
Front Psychol. 2017 Feb 09;8:120. doi: 10.3389/fpsyg.2017.00120. eCollection 2017.

Models of associative learning have proposed that cue-outcome learning critically depends on the degree of prediction error encountered during training. Two experiments examined the role of error-driven extinction learning in a human causal learning task. Target cues underwent extinction...

Cite
Griffiths O, Holmes N, Westbrook RF. Compound Stimulus Presentation Does Not Deepen Extinction in Human Causal Learning. Front Psychol. 2017;8:120doi: 10.3389/fpsyg.2017.00120.
Griffiths, O., Holmes, N., & Westbrook, R. F. (2017). Compound Stimulus Presentation Does Not Deepen Extinction in Human Causal Learning. Frontiers in psychology, 8120. https://doi.org/10.3389/fpsyg.2017.00120
Griffiths, Oren, et al. "Compound Stimulus Presentation Does Not Deepen Extinction in Human Causal Learning." Frontiers in psychology vol. 8 (2017): 120. doi: https://doi.org/10.3389/fpsyg.2017.00120
Griffiths O, Holmes N, Westbrook RF. Compound Stimulus Presentation Does Not Deepen Extinction in Human Causal Learning. Front Psychol. 2017 Feb 09;8:120. doi: 10.3389/fpsyg.2017.00120. eCollection 2017. PMID: 28232809; PMCID: PMC5298964.
Copy Download .nbib Format: NLM
A Case of Cholera Treated by Hypodermic Injections of Choloral Hydrate.

The Indian medical gazette

Griffiths G.
PMID: 28997843
Ind Med Gaz. 1878 Dec 02;13(12):334-336.

No abstract available.

Cite
Griffiths G. A Case of Cholera Treated by Hypodermic Injections of Choloral Hydrate. Ind Med Gaz. 1878;13(12):334-336
Griffiths, G. (1878). A Case of Cholera Treated by Hypodermic Injections of Choloral Hydrate. The Indian medical gazette, 13(12), 334-336.
Griffiths, G. "A Case of Cholera Treated by Hypodermic Injections of Choloral Hydrate." The Indian medical gazette vol. 13,12 (1878): 334-336.
Griffiths G. A Case of Cholera Treated by Hypodermic Injections of Choloral Hydrate. Ind Med Gaz. 1878 Dec 02;13(12):334-336. PMID: 28997843; PMCID: PMC5137360.
Copy Download .nbib Format: NLM
Efficient laboratory evolution of computationally designed enzymes with low starting activities using fluorescence-activated droplet sorting.

Protein engineering, design & selection : PEDS

Obexer R, Pott M, Zeymer C, Griffiths AD, Hilvert D.
PMID: 28873983
Protein Eng Des Sel. 2017 Jul 01;30(7):531. doi: 10.1093/protein/gzx032.

No abstract available.

Cite
Obexer R, Pott M, Zeymer C, et al. Efficient laboratory evolution of computationally designed enzymes with low starting activities using fluorescence-activated droplet sorting. Protein Eng Des Sel. 2017;30(7):531doi: 10.1093/protein/gzx032.
Obexer, R., Pott, M., Zeymer, C., Griffiths, A. D., & Hilvert, D. (2017). Efficient laboratory evolution of computationally designed enzymes with low starting activities using fluorescence-activated droplet sorting. Protein engineering, design & selection : PEDS, 30(7), 531. https://doi.org/10.1093/protein/gzx032
Obexer, Richard, et al. "Efficient laboratory evolution of computationally designed enzymes with low starting activities using fluorescence-activated droplet sorting." Protein engineering, design & selection : PEDS vol. 30,7 (2017): 531. doi: https://doi.org/10.1093/protein/gzx032
Obexer R, Pott M, Zeymer C, Griffiths AD, Hilvert D. Efficient laboratory evolution of computationally designed enzymes with low starting activities using fluorescence-activated droplet sorting. Protein Eng Des Sel. 2017 Jul 01;30(7):531. doi: 10.1093/protein/gzx032. PMID: 28873983.
Copy Download .nbib Format: NLM
Inflammatory Bowel Disease.

Adolescent medicine (Philadelphia, Pa.)

Griffiths AM.
PMID: 10358322
Adolesc Med. 1995 Oct;6(3):351-368.

Inflammatory disease comprises at least two forms of chronic intestinal inflammation: Crohn's disease and ulcerative colitis. This article reviews the epidemiology, cause and pathogenesis, clinical presentation and course, potential complications, and treatment of both Crohn's disease and ulcerative colitis.

Cite
Griffiths AM. Inflammatory Bowel Disease. Adolesc Med. 1995;6(3):351-368
Griffiths, A. M. (1995). Inflammatory Bowel Disease. Adolescent medicine (Philadelphia, Pa.), 6(3), 351-368.
Griffiths. "Inflammatory Bowel Disease." Adolescent medicine (Philadelphia, Pa.) vol. 6,3 (1995): 351-368.
Griffiths AM. Inflammatory Bowel Disease. Adolesc Med. 1995 Oct;6(3):351-368. PMID: 10358322.
Copy Download .nbib Format: NLM
Authors' reply. Mitochondrial DNA damage and oncocytic neoplasia.

The Journal of pathology

Lewis PD, Baxter PW, Griffiths AP, Parry JM, Skibinski DO.
PMID: 11113880
J Pathol. 2000 Dec;192(4):562-3. doi: 10.1002/1096-9896(200012)192:4<562::AID-PATH791>3.0.CO;2-#.

No abstract available.

Cite
Lewis PD, Baxter PW, Griffiths AP, et al. Authors' reply. Mitochondrial DNA damage and oncocytic neoplasia. J Pathol. 2000;192(4):562-3doi: 10.1002/1096-9896(200012)192:4<562::AID-PATH791>3.0.CO;2-#.
Lewis, P. D., Baxter, P. W., Griffiths, A. P., Parry, J. M., & Skibinski, D. O. (2000). Authors' reply. Mitochondrial DNA damage and oncocytic neoplasia. The Journal of pathology, 192(4), 562-3. https://doi.org/10.1002/1096-9896(200012)192:4<562::AID-PATH791>3.0.CO;2-#
Lewis, et al. "Authors' reply. Mitochondrial DNA damage and oncocytic neoplasia." The Journal of pathology vol. 192,4 (2000): 562-3. doi: https://doi.org/10.1002/1096-9896(200012)192:4<562::AID-PATH791>3.0.CO;2-#
Lewis PD, Baxter PW, Griffiths AP, Parry JM, Skibinski DO. Authors' reply. Mitochondrial DNA damage and oncocytic neoplasia. J Pathol. 2000 Dec;192(4):562-3. doi: 10.1002/1096-9896(200012)192:4<562::AID-PATH791>3.0.CO;2-#. PMID: 11113880.
Copy Download .nbib Format: NLM
Types of leadership in the veterinary community.

Journal of the American Veterinary Medical Association

Griffiths AO.
PMID: 11043681
J Am Vet Med Assoc. 2000 Oct 15;217(8):1138-9.

No abstract available.

Cite
Griffiths AO. Types of leadership in the veterinary community. J Am Vet Med Assoc. 2000;217(8):1138-9
Griffiths, A. O. (2000). Types of leadership in the veterinary community. Journal of the American Veterinary Medical Association, 217(8), 1138-9.
Griffiths, A O. "Types of leadership in the veterinary community." Journal of the American Veterinary Medical Association vol. 217,8 (2000): 1138-9.
Griffiths AO. Types of leadership in the veterinary community. J Am Vet Med Assoc. 2000 Oct 15;217(8):1138-9. PMID: 11043681.
Copy Download .nbib Format: NLM
Novel Syntheses of 2-Butyl-5-chloro-3H-imidazole-4-carbaldehyde: A Key Intermediate for the Synthesis of the Angiotensin II Antagonist Losartan.

The Journal of organic chemistry

Griffiths GJ, Hauck MB, Imwinkelried R, Kohr J, Roten CA, Stucky GC, Gosteli J.
PMID: 11674720
J Org Chem. 1999 Oct 29;64(22):8084-8089. doi: 10.1021/jo9824910.

Reaction of glycine methyl ester (19) with imidate 18 under carefully optimized conditions allowed preparation of the rather unstable imidazolinone 11 in ca. 90% yield. Reaction of 11 with POCl(3)/DMF followed by aqueous workup gave aldehyde 2, a key...

Cite
Griffiths GJ, Hauck MB, Imwinkelried R, et al. Novel Syntheses of 2-Butyl-5-chloro-3H-imidazole-4-carbaldehyde: A Key Intermediate for the Synthesis of the Angiotensin II Antagonist Losartan. J Org Chem. 1999;64(22):8084-8089doi: 10.1021/jo9824910.
Griffiths, G. J., Hauck, M. B., Imwinkelried, R., Kohr, J., Roten, C. A., Stucky, G. C., & Gosteli, J. (1999). Novel Syntheses of 2-Butyl-5-chloro-3H-imidazole-4-carbaldehyde: A Key Intermediate for the Synthesis of the Angiotensin II Antagonist Losartan. The Journal of organic chemistry, 64(22), 8084-8089. https://doi.org/10.1021/jo9824910
Griffiths, Gareth J., et al. "Novel Syntheses of 2-Butyl-5-chloro-3H-imidazole-4-carbaldehyde: A Key Intermediate for the Synthesis of the Angiotensin II Antagonist Losartan." The Journal of organic chemistry vol. 64,22 (1999): 8084-8089. doi: https://doi.org/10.1021/jo9824910
Griffiths GJ, Hauck MB, Imwinkelried R, Kohr J, Roten CA, Stucky GC, Gosteli J. Novel Syntheses of 2-Butyl-5-chloro-3H-imidazole-4-carbaldehyde: A Key Intermediate for the Synthesis of the Angiotensin II Antagonist Losartan. J Org Chem. 1999 Oct 29;64(22):8084-8089. doi: 10.1021/jo9824910. PMID: 11674720.
Copy Download .nbib Format: NLM
'Brooke of Manchester'.

The British journal of dermatology

Bhushan M, Griffiths CE.
PMID: 10886131
Br J Dermatol. 2000 Jul;143(1):26-9. doi: 10.1046/j.1365-2133.2000.03585.x.

We present a brief account of the life and times of Dr Henry Grundy Brooke, a Manchester dermatologist and key figure in British dermatology in the nineteenth century. Our report highlights the achievements of a man whose contributions to...

Cite
Bhushan M, Griffiths CE. 'Brooke of Manchester'. Br J Dermatol. 2000;143(1):26-9doi: 10.1046/j.1365-2133.2000.03585.x.
Bhushan, M., & Griffiths, C. E. (2000). 'Brooke of Manchester'. The British journal of dermatology, 143(1), 26-9. https://doi.org/10.1046/j.1365-2133.2000.03585.x
Bhushan, M, and Griffiths, C E. "'Brooke of Manchester'." The British journal of dermatology vol. 143,1 (2000): 26-9. doi: https://doi.org/10.1046/j.1365-2133.2000.03585.x
Bhushan M, Griffiths CE. 'Brooke of Manchester'. Br J Dermatol. 2000 Jul;143(1):26-9. doi: 10.1046/j.1365-2133.2000.03585.x. PMID: 10886131.
Copy Download .nbib Format: NLM
Rapid isolation and separation of the non-histone proteins of rat liver nuclei.

FEBS letters

Gronow M, Griffiths G.
PMID: 11945878
FEBS Lett. 1971 Jul 08;15(5):340-344. doi: 10.1016/0014-5793(71)80329-0.

No abstract available.

Cite
Gronow M, Griffiths G. Rapid isolation and separation of the non-histone proteins of rat liver nuclei. FEBS Lett. 1971;15(5):340-344doi: 10.1016/0014-5793(71)80329-0.
Gronow, M., & Griffiths, G. (1971). Rapid isolation and separation of the non-histone proteins of rat liver nuclei. FEBS letters, 15(5), 340-344. https://doi.org/10.1016/0014-5793(71)80329-0
Gronow, M, and Griffiths, G. "Rapid isolation and separation of the non-histone proteins of rat liver nuclei." FEBS letters vol. 15,5 (1971): 340-344. doi: https://doi.org/10.1016/0014-5793(71)80329-0
Gronow M, Griffiths G. Rapid isolation and separation of the non-histone proteins of rat liver nuclei. FEBS Lett. 1971 Jul 08;15(5):340-344. doi: 10.1016/0014-5793(71)80329-0. PMID: 11945878.
Copy Download .nbib Format: NLM
Advances in the use of monoclonal antibodies in cancer radiotherapy.

Pharmaceutical science & technology today

Govindan SV, Goldenberg DM, Hansen HJ, Griffiths GL.
PMID: 10707044
Pharm Sci Technol Today. 2000 Mar;3(3):90-98. doi: 10.1016/s1461-5347(00)00241-8.

The use of monoclonal antibodies (MAbs) as radiation carriers in argeted radiotherapy of cancers has produced striking clinical responses in hematologic diseases, such as non-Hodgkin's lymphoma. Novel strategies are currently being examined in an effort to improve efficacy in...

Cite
Govindan SV, Goldenberg DM, Hansen HJ, et al. Advances in the use of monoclonal antibodies in cancer radiotherapy. Pharm Sci Technol Today. 2000;3(3):90-98doi: 10.1016/s1461-5347(00)00241-8.
Govindan, S. V., Goldenberg, D. M., Hansen, H. J., & Griffiths, G. L. (2000). Advances in the use of monoclonal antibodies in cancer radiotherapy. Pharmaceutical science & technology today, 3(3), 90-98. https://doi.org/10.1016/s1461-5347(00)00241-8
Govindan, et al. "Advances in the use of monoclonal antibodies in cancer radiotherapy." Pharmaceutical science & technology today vol. 3,3 (2000): 90-98. doi: https://doi.org/10.1016/s1461-5347(00)00241-8
Govindan SV, Goldenberg DM, Hansen HJ, Griffiths GL. Advances in the use of monoclonal antibodies in cancer radiotherapy. Pharm Sci Technol Today. 2000 Mar;3(3):90-98. doi: 10.1016/s1461-5347(00)00241-8. PMID: 10707044.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 260 entries